Secukinumab in Patients with Psoriasis and a Personal History of Malignancy: A Multicenter Real-Life Observational Study

INTRODUCTION: There is limited evidence to guide clinicians on the treatment of psoriasis with biologics in patients with a history of malignancy who are often excluded from clinical trials investigating biologics. The aim of this work is to report a multicenter real-life experience of secukinumab t...

Descripción completa

Detalles Bibliográficos
Autores principales: Pellegrini, Cristina, Esposito, Maria, Rossi, Ernesto, Gisondi, Paolo, Piaserico, Stefano, Dapavo, Paolo, Conti, Andrea, Gambardella, Alessio, Burlando, Martina, Narcisi, Alessandra, Offidani, Annamaria, Balestri, Riccardo, Bardazzi, Federico, Prignano, Francesca, Mugheddu, Cristina, Romanelli, Marco, Malara, Giovanna, Schinzari, Giovanni, Fargnoli, Maria Concetta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588094/
https://www.ncbi.nlm.nih.gov/pubmed/36169883
http://dx.doi.org/10.1007/s13555-022-00797-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588094/
https://www.ncbi.nlm.nih.gov/pubmed/36169883
http://dx.doi.org/10.1007/s13555-022-00797-9

Ejemplares similares